Nitec Pharma develops therapeutics for pain and chronic inflammation.
Nitec Pharma AG
Facts from the Community
From the BioVenturist base
Technology Focus:
Investment Round:
| Amount raised | Date | Investors |
|---|---|---|
|
|
We can tell you that Nitec Pharma AG is a…
If you know more about Nitec Pharma AG, you can add more facts here »
Similar topics in Freebase
-
Regulus Therapeutics
-
Xenome Ltd.
Xenome develops peptide drugs for the treatment of pain and inflammation. -
Anacor Pharmaceuticals Inc.
Anacor Pharmaceuticals is developing small-molecule therapeutics using their boron chemistry platform. -
ImClone Systems
ImClone Systems Incorporated is a biopharmaceutical company dedicated to developing biologic medicines in the area of oncology. It was founded in 1984 and is headquartered in New York City. On October 6, 2008, it accepted a $6.5 billion acquisition offer from Eli Lilly and Company, and became a... -
Dendreon
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer. It consists of a mixture of the patient's own blood cells (autologous, with dendritic cells thought to be the most important)... -
Aposense Ltd.
Aposense develops agents that target apoptosis both for therapies and molecular imaging agents. -
QLT Inc.
-
Axikin Pharmaceuticals Inc.
Axikin is developing small molecule therapeutics for respiratory and inflammatory disease. -
Johnson & Johnson
Johnson & Johnson (NYSE: JNJ) is an American multinational medical devices, pharmaceutical and consumer packaged goods manufacturer founded in 1886. Its common stock is a component of the Dow Jones Industrial Average and the company is listed among the Fortune 500. Johnson & Johnson consistently... -
Napo Pharmaceuticals
Napo is a developer of products for first world and emerging markets. Napo's first drug, crofelemer, is in clinical trials for gastrointestinal indications.
You can help improve this topic by adding more facts here
